Abeona Therapeutics® to Present at the Leerink Partners Global Healthcare Conference

Core Insights - Abeona Therapeutics Inc. will have its CEO, Vish Seshadri, present at the Leerink Partners Global Healthcare Conference on March 10, 2025 [1] - A live webcast of the presentation will be available on the company's website and archived for 30 days [2] Company Overview - Abeona Therapeutics is a clinical-stage biopharmaceutical company focused on developing cell and gene therapies for serious diseases [3] - The company is working on Prademagene zamikeracel (pz-cel), an investigational autologous, COL7A1 gene-corrected epidermal sheet for recessive dystrophic epidermolysis bullosa [3] - Abeona has a fully integrated cGMP manufacturing facility that supports the production of pz-cel for its Phase 3 VIITAL™ trial and future commercial production upon FDA approval [3] - The company also has AAV-based gene therapies targeting ophthalmic diseases with high unmet medical needs, utilizing next-generation AAV capsids to enhance tropism profiles [3]